highlight / actuality
Researchers at the laboratory study hereditary hemorrhagic telangiectasia type 1 and develop a cellular test to discriminate between genetic variants without functional consequences, and mutants that can be predicted to be pathogenic. This test can be used by geneticists as a diagnostic tool for the study of new mutations and opens the way to new therapeutic perspectives.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.